Discounted Cash Flow Rating
Neutral
Return on Equity Rating
Sell
Debt to Equity Rating
Sell
Price to Earnings Rating
Sell
Analyst Rating
Neutral
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Neutral
Williams %R
Strong Buy
Average Directional Index
Sell
Insider Trading
Neutral
Wall Street Data Solutions Rating
Neutral
B
Trevi Therapeutics, Inc. Common Stock (TRVI)
Pharmaceutical Preparations
https://www.trevitherapeutics.com
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
195 CHURCH STREET, 14TH FLOOR
NEW HAVEN, CT
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
05/03/2019
Market Cap
194,400,876
Shares Outstanding
63,860,000
Weighted SO
63,857,622
Total Employees
N/A
Upcoming Earnings
08/08/2024
Beta
1.0080
Last Div
0.0000
Range
0.97-4.0
Chg
0.0100
Avg Vol
233675
Mkt Cap
194400876
Exch
NASDAQ
Country
US
Phone
203 304 2499
DCF Diff
2.4564
DCF
0.3136
Div Yield
0.0000
P/S
1104.5504
EV Multiple
-4.2408
P/FV
4.2143
Div Yield %
0.0000
P/E
-7.1925
PEG
-0.2023
Payout
0.0000
Current Ratio
10.6826
Quick Ratio
10.6826
Cash Ratio
1.9199
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
3856.7483
CCC
-3856.7483
Gross Margin
0.1875
Op Margin
-245.3011
Pretax Margin
-220.3636
Net Margin
-220.3011
Eff Tax Rate
0.0003
ROA
-0.5253
ROE
-0.4992
ROCE
-0.6438
NI/EBT
0.9997
EBT/EBIT
0.8983
EBIT/Rev
-245.3011
Debt Ratio
0.0162
D/E
0.0180
LT Debt/Cap
0.0132
Total Debt/Cap
0.0177
Int Coverage
-43173.0000
CF/Debt
-27.4837
Equity Multi
1.1154
Rec Turnover
0.0000
Pay Turnover
0.0946
Inv Turnover
0.0000
FA Turnover
0.1250
Asset Turnover
0.0024
OCF/Share
-0.3245
FCF/Share
-0.3252
Cash/Share
0.6878
OCF/Sales
-186.2955
FCF/OCF
1.0021
CF Coverage
-27.4837
ST Coverage
-106.1100
CapEx Coverage
-482.1765
Div&CapEx Cov
-482.1765
P/BV
4.2143
P/B
4.2143
P/S
1104.5504
P/E
-7.1925
P/FCF
-5.9168
P/OCF
-8.5054
P/CF
-8.5054
PEG
-0.2023
P/S
1104.5504
EV Multiple
-4.2408
P/FV
4.2143
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
3 - 6 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
6 - 9 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 176.00K | ▼ 0.00 |
Cost Of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 15.00K | ▲ 35.00K | 35.00K |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -15.00K | ▲ 141.00K | ▼ -35.00K |
Gross Profit Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 0.80 | ▼ 0.00 |
Research And Development Expenses | 4.52M | ▲ 4.82M | ▲ 6.56M | ▼ 6.18M | ▼ 4.32M | ▲ 6.52M | ▲ 8.80M |
General And Administrative Expenses | 1.41M | ▲ 1.94M | ▲ 2.63M | ▼ 2.09M | ▲ 2.34M | ▲ 2.42M | ▲ 3.10M |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -35.00K | -35.00K |
Selling General And Administrative Expenses | 1.41M | ▲ 1.94M | ▲ 2.63M | ▼ 2.09M | ▲ 2.34M | ▲ 2.38M | ▲ 3.07M |
Other Expenses | -148.00K | ▲ 225.00K | ▼ -313.00K | ▲ 0.00 | ▲ 1.13M | ▼ -3.00K | ▲ -1.00K |
Operating Expenses | 5.93M | ▲ 6.77M | ▲ 9.19M | ▼ 8.27M | ▼ 6.66M | ▲ 8.90M | ▲ 11.87M |
Cost And Expenses | 5.93M | ▲ 6.77M | ▲ 9.19M | ▼ 8.27M | ▼ 6.66M | ▲ 8.93M | ▲ 11.91M |
Interest Income | 46.00K | ▲ 225.00K | ▼ 4.00K | ▼ 3.00K | ▲ 1.12M | ▲ 1.14M | ▼ 998.00K |
Interest Expense | 0.00 | 0.00 | ▲ 308.00K | ▲ 664.00K | ▼ 200.00K | ▼ 4.00K | ▼ 1.00K |
Depreciation And Amortization | 13.00K | ▼ 9.00K | ▲ 13.00K | ▼ 12.00K | ▲ 15.00K | ▲ 35.00K | 35.00K |
Ebitda | -6.02M | ▼ -6.77M | ▼ -9.19M | ▲ -7.90M | ▲ -6.66M | ▼ -8.90M | ▼ -11.87M |
Ebitda Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -50.56 | ▲ 0.00 |
Operating Income | -5.93M | ▼ -6.77M | ▼ -9.19M | ▲ -8.27M | ▲ -6.66M | ▼ -8.93M | ▼ -11.91M |
Operating Income Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -50.76 | ▲ 0.00 |
Total Other Income Expenses Net | -148.00K | ▲ 225.00K | ▼ -313.00K | ▲ 53.00K | ▲ 1.13M | ▼ 1.13M | ▼ 996.00K |
Income Before Tax | -6.03M | ▼ -6.54M | ▼ -9.51M | ▲ -8.53M | ▲ -5.52M | ▼ -7.80M | ▼ -10.91M |
Income Before Tax Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -44.34 | ▲ 0.00 |
Income Tax Expense | -49.00K | ▲ -4.00K | ▲ 17.00K | ▼ -6.00K | ▼ -20.00K | ▲ 18.00K | ▼ -8.00K |
Net Income | -5.98M | ▼ -6.54M | ▼ -9.52M | ▲ -8.52M | ▲ -5.50M | ▼ -7.82M | ▼ -10.90M |
Net Income Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -44.44 | ▲ 0.00 |
Eps | -0.34 | ▼ -0.37 | ▼ -0.51 | ▲ -0.39 | ▲ -0.06 | ▼ -0.08 | ▼ -0.11 |
Eps Diluted | -0.34 | ▼ -0.37 | ▼ -0.51 | ▲ -0.39 | ▲ -0.06 | ▼ -0.08 | ▼ -0.11 |
Weighted Average Shs Out | 17.77M | ▲ 17.83M | ▲ 18.55M | ▲ 21.61M | ▲ 98.13M | ▲ 99.49M | ▲ 99.52M |
Weighted Average Shs Out Dil | 17.77M | ▲ 17.83M | ▲ 18.55M | ▲ 21.61M | ▲ 98.13M | ▲ 99.49M | ▲ 99.52M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 17.17M | ▲ 57.31M | ▼ 45.00M | ▼ 36.83M | ▼ 12.59M | ▲ 32.40M | ▼ 13.81M |
Short Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 107.92M | ▼ 50.57M | ▲ 59.01M |
Cash And Short Term Investments | 17.17M | ▲ 57.31M | ▼ 45.00M | ▼ 36.83M | ▼ 12.59M | ▲ 82.97M | ▼ 72.82M |
Net Receivables | 184.00K | ▲ 558.00K | ▼ 265.00K | ▼ 241.00K | ▼ 0.00 | 0.00 | 0.00 |
Inventory | 1.40M | ▲ 1.60M | ▼ 895.00K | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Other Current Assets | 42.00K | ▲ 77.00K | ▲ 108.00K | ▲ 886.00K | ▲ 1.31M | ▲ 4.58M | ▼ 3.95M |
Total Current Assets | 18.79M | ▲ 59.55M | ▼ 46.27M | ▼ 37.96M | ▲ 122.62M | ▼ 87.55M | ▼ 76.77M |
Property Plant Equipment Net | 149.00K | ▲ 430.00K | ▼ 330.00K | ▼ 184.00K | ▲ 194.00K | ▲ 1.56M | ▼ 1.48M |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill And Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Long Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Assets | 1.55M | ▼ 19.00K | ▲ 532.00K | ▼ 334.00K | ▼ 205.00K | ▲ 297.00K | ▲ 311.00K |
Total Non Current Assets | 1.70M | ▼ 449.00K | ▲ 862.00K | ▼ 518.00K | ▼ 399.00K | ▲ 1.86M | ▼ 1.79M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 |
Total Assets | 20.49M | ▲ 60.00M | ▼ 47.13M | ▼ 38.48M | ▲ 123.02M | ▼ 89.40M | ▼ 78.56M |
Account Payables | 603.00K | ▲ 1.60M | ▲ 2.02M | ▲ 2.85M | ▲ 2.86M | ▼ 1.81M | ▲ 2.11M |
Short Term Debt | 0.00 | ▲ 99.00K | ▲ 113.00K | ▲ 5.95M | ▲ 7.03M | ▼ 306.00K | ▲ 322.00K |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Revenue | 0.00 | 0.00 | 0.00 | ▲ 3.81M | ▼ 0.00 | 0.00 | 0.00 |
Other Current Liabilities | 2.07M | ▲ 3.50M | ▼ 3.43M | ▼ 114.00K | ▲ 3.52M | ▲ 3.71M | ▼ 2.84M |
Total Current Liabilities | 2.68M | ▲ 5.20M | ▲ 5.56M | ▲ 12.72M | ▲ 13.40M | ▼ 5.82M | ▼ 5.28M |
Long Term Debt | 0.00 | ▲ 257.00K | ▲ 14.10M | ▼ 8.68M | ▼ 2.15M | ▼ 1.03M | ▼ 949.00K |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Liabilities | 506.00K | ▼ 0.00 | ▲ 196.00K | ▼ 0.00 | ▲ 3.00K | ▼ 0.00 | ▼ -1.00 |
Total Non Current Liabilities | 506.00K | ▼ 257.00K | ▲ 14.29M | ▼ 8.68M | ▼ 2.16M | ▼ 1.03M | ▼ 949.00K |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 |
Capital Lease Obligations | 0.00 | ▲ 356.00K | ▼ 257.00K | ▼ 144.00K | ▼ 27.00K | ▲ 1.03M | ▼ 949.00K |
Total Liabilities | 3.18M | ▲ 5.46M | ▲ 19.85M | ▲ 21.40M | ▼ 15.56M | ▼ 6.86M | ▼ 6.23M |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 101.00K | ▼ 18.00K | ▲ 19.00K | ▲ 29.00K | ▲ 60.00K | ▲ 68.00K | ▲ 69.00K |
Retained Earnings | -109.50M | ▼ -114.22M | ▼ -146.98M | ▼ -180.92M | ▼ -210.07M | ▼ -239.13M | ▼ -250.04M |
Accumulated Other Comprehensive Income Loss | -46.00K | ▼ -85.00K | ▲ 0.00 | 0.00 | ▼ -122.00K | ▲ -29.00K | ▼ -67.00K |
Other Total Stockholders Equity | 126.75M | ▲ 168.83M | ▲ 174.24M | ▲ 197.96M | ▲ 317.59M | ▲ 321.64M | ▲ 322.37M |
Total Stockholders Equity | 17.31M | ▲ 54.55M | ▼ 27.28M | ▼ 17.08M | ▲ 107.46M | ▼ 82.55M | ▼ 72.33M |
Total Equity | 17.31M | ▲ 54.55M | ▼ 27.28M | ▼ 17.08M | ▲ 107.46M | ▼ 82.55M | ▼ 72.33M |
Total Liabilities And Stockholders Equity | 20.49M | ▲ 60.00M | ▼ 47.13M | ▼ 38.48M | ▲ 123.02M | ▼ 89.40M | ▼ 78.56M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 20.49M | ▲ 60.00M | ▼ 47.13M | ▼ 38.48M | ▲ 123.02M | ▼ 89.40M | ▼ 78.56M |
Total Investments | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 107.92M | ▼ 50.57M | ▲ 59.01M |
Total Debt | 0.00 | ▲ 356.00K | ▲ 14.21M | ▲ 14.63M | ▼ 9.18M | ▼ 1.34M | ▼ 1.27M |
Net Debt | -17.17M | ▼ -56.96M | ▲ -30.79M | ▲ -22.20M | ▲ -3.41M | ▼ -31.06M | ▲ -12.54M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2018 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -5.98M | ▼ -6.54M | ▼ -9.52M | ▲ -8.52M | ▲ -5.51M | ▼ -7.82M | ▼ -10.90M |
Depreciation And Amortization | 13.00K | ▼ 9.00K | ▲ 13.00K | ▼ 12.00K | ▲ 15.00K | ▲ 35.00K | 35.00K |
Deferred Income Tax | 0.00 | ▼ -1.58M | ▲ 9.00K | ▼ -53.00K | ▲ 0.00 | ▲ 23.00K | ▼ 0.00 |
Stock Based Compensation | 185.00K | ▲ 373.00K | ▲ 510.00K | ▲ 540.00K | ▼ 501.00K | ▲ 534.00K | ▲ 723.00K |
Change In Working Capital | 902.00K | ▼ -47.00K | ▼ -92.00K | ▲ 1.64M | ▼ -882.00K | ▲ 736.00K | ▼ -62.00K |
Accounts Receivables | 0.00 | ▼ -374.00K | ▲ -206.00K | ▲ 0.00 | 0.00 | 0.00 | 0.00 |
Inventory | 0.00 | ▼ -55.14M | ▲ -41.36M | ▲ 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payables | -58.00K | ▲ 1.11M | ▼ 758.00K | ▼ 615.00K | ▼ 536.00K | ▲ 627.00K | ▼ 294.00K |
Other Working Capital | 960.00K | ▲ 54.35M | ▼ 40.71M | ▼ 1.02M | ▼ -1.42M | ▲ 109.00K | ▼ -356.00K |
Other Non Cash Items | 148.00K | ▲ 1.58M | ▼ 159.00K | ▼ 157.00K | ▼ -460.00K | ▲ 134.00K | ▲ 238.00K |
Net Cash Provided By Operating Activities | -4.73M | ▼ -6.20M | ▼ -8.92M | ▲ -6.23M | ▼ -6.33M | ▼ -6.36M | ▼ -10.47M |
Investments In Property Plant And Equipment | -92.00K | ▲ 9.00K | ▼ -5.00K | ▲ 0.00 | ▼ -116.00K | ▲ -22.00K | ▲ 0.00 |
Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.20M | ▼ 671.00K | ▼ 0.00 |
Purchases Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -65.19M | ▲ -951.00K | ▼ -30.26M |
Sales Maturities Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 17.00M | ▼ 13.82M | ▲ 22.17M |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -1.20M | ▲ 12.87K | ▲ 381.00K |
Net Cash Used For Investing Activities | -92.00K | ▲ 9.00K | ▼ -5.00K | ▲ 0.00 | ▼ -48.31M | ▲ 12.85M | ▼ -8.09M |
Debt Repayment | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -1.75M | ▲ -32.00 | ▼ -32.00K |
Common Stock Issued | 0.00 | 0.00 | ▲ 693.00K | ▲ 13.68M | ▼ 2.40M | ▼ -1.73M | ▲ 4.00K |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -1.51K | ▲ 0.00 | ▼ -56.00K | ▲ 63.00K | ▼ 2.00K | ▼ -22.00 | ▲ 4.00K |
Net Cash Used Provided By Financing Activities | -1.51K | ▲ 0.00 | ▲ 637.00K | ▲ 13.74M | ▼ 652.00K | ▼ -54.00 | ▼ -28.00K |
Effect Of Forex Changes On Cash | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 13.87M | ▼ 0.00 |
Net Change In Cash | -6.33M | ▲ -6.20M | ▼ -8.29M | ▲ 7.51M | ▼ -53.99M | ▲ 6.43M | ▼ -18.59M |
Cash At End Of Period | 7.20M | ▲ 57.31M | ▼ 45.00M | ▼ 36.83M | ▼ 12.59M | ▲ 32.40M | ▼ 13.81M |
Cash At Beginning Of Period | 13.53M | ▲ 63.52M | ▼ 53.29M | ▼ 29.32M | ▲ 66.57M | ▼ 25.97M | ▲ 32.40M |
Operating Cash Flow | -4.73M | ▼ -6.20M | ▼ -8.92M | ▲ -6.23M | ▼ -6.33M | ▼ -6.36M | ▼ -10.47M |
Capital Expenditure | -92.00K | ▲ 9.00K | ▼ -5.00K | ▲ 0.00 | ▼ -116.00K | ▲ -22.00K | ▲ 0.00 |
Free Cash Flow | -4.83M | ▼ -6.19M | ▼ -8.93M | ▲ -6.23M | ▼ -6.45M | ▲ -6.38M | ▼ -10.47M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)